HUM
Humana
Health Care · Managed Health Care · US
$350.08
Data: 2025-12-31
✗ ETHICAL FAIL

WEAK MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$33.0B
Total market value of the company
29.30
Premium valuation
18.00
Based on estimated future earnings — lower means cheaper
Rev Growth
+23.5%
Year-over-year revenue change
Profit Margin
0.0%
How much profit the company keeps from each dollar of revenue
6.3%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$246.71
-30% from current price — median analyst estimate
Recommendation
HOLD
Consensus view from 24 analysts covering this stock
About Humana

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

https://www.humana.com

Country: United States Employees: 67,060 Industry: Healthcare Plans
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
25.3% PASS
Debt must be below 33% of total assets
Cash Ratio
34.4% FAIL
Interest-bearing cash below 33% of assets
Receivables
15.3% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
$382.00
What our model estimates this business is worth per share
8.4%
Slight discount to fair value
Rating
AVOID
Overall assessment combining ethics, valuation, and quality
51.2th
Ranks in the top 49% of our 13,571 screened universe
Ethical Score
10.0
Valuation Score
73.0
Quality Score
41.8
Combined
40.4

Trading at $275 against a fair value of $382, a 28% discount. Fails ethical screen (Interest-bearing securities). Ranks better than 55% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

MARKUP
Price trending up with increasing momentum
0.107
Positive but modest risk-adjusted returns
0.0110
Marginal edge — very small allocation suggested
-0.099
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-5.8%
Historical annualised return based on price data
-58.7%
Largest peak-to-trough decline — the worst it has been
BULL
Statistical model sees bullish momentum
Days in State
11
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

0.68
Less volatile than the market — more defensive
52W High
$315.35
-11% below the year high
52W Low
$163.11
115% above the year low
Avg Volume
1,819,274
Average daily shares traded — higher means easier to buy and sell
3.3
Days it would take all short sellers to cover — higher means more crowded
Short % Float
5.9%
Moderate short interest
129.0%
Annual dividend as a percentage of the share price
$9.38
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

0.77
Moderate leverage — manageable
1.77
Healthy liquidity position
Quick Ratio
1.26
Like current ratio but excludes inventory — stricter test
Gross Margin
14.0%
Revenue left after cost of goods — higher means pricing power
Operating Margin
4.7%
Profit from core operations before interest and tax
$1.4B
Positive — the business generates more cash than it spends
Revenue (TTM)
$137.2B
Total revenue over the last 12 months
Net Income
$1.1B
Profitable — the bottom line is positive
Analyst Coverage
Analysts
24
Target High
$333.00
Target Median
$246.71
Target Low
$146.00
Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

55
NEUTRAL
Mixed insider activity. 0 purchases and 0 sales in the last 90 days — no clear directional signal. Politicians have been buying this name.
Date Insider Title Type Shares Value
2026-05-01 VENTURA JOSEPH CHRISTOPHER Officer 10,318
2026-05-01 O'HARA MICHELLE A. Officer 10,485
2026-05-01 SHETTY SANJAY K Officer 9,945
2026-05-01 RECHTIN JAMES A. Chief Executive Officer 35,633
2026-05-01 DINTENFASS DAVID Officer 11,273
2026-05-01 MEHTA JAPAN Chief Technology Officer 9,448
2026-05-01 MELLET CELESTE Chief Financial Officer 15,387
2026-05-01 MARTIN AARON Officer 8,206
2026-05-01 FIELD ROBERT STUART Director 852
2026-04-01 SHETTY SANJAY K Officer 887
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Political Trading Activity

Congressional trading disclosures involving this instrument

Date Politician Party Type Amount
2026-04-13 Ro Khanna Democrat Purchase 1K–15K
Source: Congressional disclosure filings. View all political trades at
Insider Intelligence
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2025-12-31

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.